Assessement of the Concordance of Genomic Alterations Between Urine and Tissue in High-Risk NMIBC Patients
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Bladder Cancer
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04412070
- Collaborators
- AstraZeneca
- Investigators
- Principal Investigator: Yanish Soorojebally, MD Hopital Foch